Co-founder, Chairman and CEO
Jeff Aronin is a leading life science entrepreneur and visionary, with decades of experience, who has built a portfolio of successful, ground-breaking companies that are driving transformation across the biological and life sciences. Accelerating innovation, Jeff has created companies focused on solving some of the world’s greatest challenges using new biology-based solutions to help heal people and the world.
Evozyne is one of seven portfolio companies under Paragon Biosciences, founded by Jeff, where he serves as chairman and CEO. Paragon is a global life science leader that creates, builds and funds innovative biology-based companies in three key areas: cell and gene therapy, synthetic biology and biotechnology.
Jeff is also the founder and chairman of MATTER, a health technology incubator to support innovators, and serves on the boards of Discover Financial Services and The Aspen Institute. Jeff also is a mentor to students and young professionals and is a frequent lecturer at the University of Chicago’s Booth School of Business and Northwestern University’s Kellogg School of Business.